Abbott Says FDA Oks Navitor TAVI System To Treat Severe Aortic Stenosis

RTTNews | 651 วันที่ผ่านมา
Abbott Says FDA Oks Navitor TAVI System To Treat Severe Aortic Stenosis

(RTTNews) - Abbott Laboratories (ABT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved the company's latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor, to treat people with severe aortic stenosis who are at high or extreme risk for open-heart surgery.

The Navitor TAVI system is the latest addition to the company's comprehensive transcatheter structural heart portfolio that offers less invasive treatment options to physicians and patients for some of the most common and serious heart diseases.

Aortic stenosis occurs when the aortic valve's opening narrows, restricting blood flow to the body. Left untreated, it can lead to heart failure and death.

Navitor features a unique fabric cuff (NaviSeal) to reduce or eliminate the backflow of blood around the valve frame known as paravalvular leak (PVL). Additionally, the new device is the only self-expanding TAVI system with leaflets within the native valve.

The Navitor device is implanted using Abbott's FlexNav delivery system, which features a slim design to accommodate different patient anatomies and small vessels for stable, predictable and accurate valve delivery and placement.

แท็ก : ABT
read more
Abbott Laboratories Boosts FY24 Earnings Outlook - Update

Abbott Laboratories Boosts FY24 Earnings Outlook - Update

While reporting financial results for the second quarter on Thursday, Abbott Laboratories (ABT) provided earnings and adjusted earnings guidance for the third quarter and raised its outlook for the full-year 2024.
RTTNews | 103 วันที่ผ่านมา
Abbott Laboratories Says FDA Approves Assert-IQ Insertable Cardiac Monitor

Abbott Laboratories Says FDA Approves Assert-IQ Insertable Cardiac Monitor

Abbott Laboratories (ABT) announced Thursday that its Assert-IQ insertable cardiac monitor (ICM) has received U.S. Food and Drug Administration (FDA) clearance, giving physicians a new option for diagnostic evaluation and long-term monitoring of people experiencing irregular heartbeats.
RTTNews | 530 วันที่ผ่านมา
Abbott Says FDA Approves Spinal Cord Stimulation Devices To Treat Chronic Back Pain

Abbott Says FDA Approves Spinal Cord Stimulation Devices To Treat Chronic Back Pain

Abbott Laboratories (ABT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of chronic back pain in people who have not had or are not eligible to receive back surgery, known as non-surgical back pain.
RTTNews | 532 วันที่ผ่านมา